Tag: Disease-modifying antirheumatic drugs

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Disease-modifying antirheumatic drugs

FDA Accepts Review of Biologics License Application for AVT05, a Biosimilar Candidate for ...

Added to Collection on: 2025-01-30 08:40:44

Tags for this article:

Monoclonal antibodies
TNF inhibitors
Immunosuppressants
Disease-modifying antirheumatic drugs
Janssen Biotech
Biopharmaceutical
Golimumab
Biosimilar
Adalimumab
Ustekinumab
Psoriatic arthritis
Teva Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Arthritis Monoclonal Antibodies Market Set to Reach $83.76 - openPR.com

Added to Collection on: 2025-02-20 22:06:33

Tags for this article:

Monoclonal antibodies
TNF inhibitors
Disease-modifying antirheumatic drugs
Immunosuppressants
Immunology
Golimumab
Arthritis
Antibody
Celltrion
Sanofi
Certolizumab pegol
Roche

Click the tags to see associated articles and topics

View Article Details
Long-Term Safety and Efficacy of Ixekizumab in Japanese Patients with Psoriasis

Added to Collection on: 2025-03-20 19:13:55

Tags for this article:

Psoriasis
Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
Autoimmune diseases
Generalized pustular psoriasis
Psoriatic arthritis
Ixekizumab
Psoriatic erythroderma
Biopharmaceutical
Adalimumab
Interleukin-17A
Japan

Click the tags to see associated articles and topics

View Article Details
Sandoz Sues Amgen Over Enbrel Biosimilar - Law360 Healthcare Authority

Added to Collection on: 2025-04-14 19:24:58

Tags for this article:

Immunosuppressants
TNF inhibitors
Disease-modifying antirheumatic drugs
Amgen
Sandoz
Biosimilar
Etanercept
Blockbuster

Click the tags to see associated articles and topics

View Article Details
Celltrion Adalimumab Biosimilar Granted Interchangeability Designation - Goodwin

Added to Collection on: 2025-04-19 11:16:31

Tags for this article:

Monoclonal antibodies
Immunosuppressants
TNF inhibitors
Disease-modifying antirheumatic drugs
Adalimumab
Celltrion
Biosimilar
Hidradenitis suppurativa
Hidradenitis
Arthritis
Ulcerative colitis
Ankylosing spondylitis
Celltrion Inc.

Click the tags to see associated articles and topics

View Article Details
Q&A: Reframing JAK Inhibitor Safety and Flexibility in AD With Leon Kircik, MD

Added to Collection on: 2025-06-07 17:50:18

Tags for this article:

Disease-modifying antirheumatic drugs
Immunosuppressants
Autoimmune diseases
Janus kinase inhibitor
Tofacitinib
Sulfonamides
Abrocitinib
Atopic dermatitis
Ruxolitinib
Upadacitinib
Janus kinase
Etanercept
Nashville

Click the tags to see associated articles and topics

View Article Details
Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT2506, a ...

Added to Collection on: 2025-07-16 18:01:32

Tags for this article:

Monoclonal antibodies
Orphan drugs
Immunosuppressants
Disease-modifying antirheumatic drugs
Specialty drugs
Golimumab
Biopharmaceutical
Biosimilar
Adalimumab
Intas Pharmaceuticals
Bevacizumab
Ustekinumab
Bio-Thera Solutions
Thera Solutions, Ltd.
United States

Click the tags to see associated articles and topics

View Article Details
Biologics Market Will Estimated to Reach 1,140.2 Bn by 2035, Driven by Precision Medicine ...

Added to Collection on: 2025-08-13 12:16:57

Tags for this article:

Pharmacy
Disease-modifying antirheumatic drugs
Immunosuppressants
TNF inhibitors
Biotechnology
Biopharmaceutical
Samsung Biologics
Biosimilar
Pharmaceutical industry in India
Biocon
Novartis
Food and Drug Administration
Transparency Market Research Inc.
United States
Market Research Inc.

Click the tags to see associated articles and topics

View Article Details
Ankylosing Spondylitis Market Size to Hit USD 11.15 Billion - GlobeNewswire

Added to Collection on: 2025-08-21 13:53:46

Tags for this article:

Immunosuppressants
Monoclonal antibodies
TNF inhibitors
Disease-modifying antirheumatic drugs
Biotechnology
Biopharmaceutical
Ankylosing spondylitis
Adalimumab
Etanercept
Biosimilar
Infliximab
Spondyloarthritis

Click the tags to see associated articles and topics

View Article Details
Accord BioPharma Announces Commercial Launch of IMULDOSA® (ustekinumab-srlf ... - JD Supra

Added to Collection on: 2025-08-26 17:19:32

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Autoimmune diseases
Disease-modifying antirheumatic drugs
Janssen Biotech
Ustekinumab
Psoriatic arthritis
Biosimilar
Psoriasis
Syringe
Accord BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo